https://udic.es/el-hospital-universitari-general-de-catalunya-evalua-un-nuevo-medicamento-para-corregir-los-sintomas-del-parkinson/2019-02-07T13:49:50+01:00https://udic.es/%e2%80%8blhospital-general-de-catalunya-participa-en-estudi-per-frenar-la-progressio-del-parkinson/2019-02-07T13:48:34+01:00https://udic.es/%e2%80%8blhospital-general-de-catalunya-participa-en-estudi-per-frenar-la-progressio-del-parkinson/2019-01-24T10:02:32+01:00https://udic.es/el-hospital-universitari-general-de-catalunya-evalua-un-nuevo-medicamento-para-corregir-los-sintomas-del-parkinson/2019-01-24T09:46:50+01:00https://udic.es/udic-premio-al-mejor-equipo-de-los-que-participan-en-el-ensayo-mission/2019-02-08T13:17:44+01:00https://udic.es/udic-premi-al-millor-equip-dels-quals-participen-en-lassaig-mission/2019-02-07T13:31:43+01:00https://udic.es/9872/2019-02-07T13:28:21+01:00https://udic.es/resultado-positivo-del-ensayo-ambar-en-alzheimer-en-fase-moderada/2019-02-08T13:17:34+01:00https://udic.es/resultat-positiu-de-lassaig-ambar-en-alzheimer-en-fase-moderada/2019-02-07T14:08:43+01:00https://udic.es/positive-result-of-the-ambar-study-in-moderate-stage-in-alzheimers-disease/2019-02-08T13:18:55+01:00https://udic.es/nuevo-ensayo-de-fase-i-en-parkinson-inicial/2019-09-02T10:43:55+02:00https://udic.es/nou-assaig-de-fase-i-en-parkinson-inicial/2019-09-10T12:03:35+02:00https://udic.es/new-phase-i-clinical-trial-in-early-parkinsons/2019-09-10T12:04:11+02:00https://udic.es/agradecimientos/2024-02-14T16:10:28+01:00https://udic.es/agraiments/2019-02-14T10:22:55+01:00https://udic.es/gratitude/2019-02-14T10:23:41+01:00https://udic.es/jornada-de-intercambio-uic-y-fundacio-ace/2019-02-14T10:33:26+01:00https://udic.es/jornada-dintercanvi-uic-i-fundacio-ace/2019-02-14T10:34:27+01:00https://udic.es/exchange-conference-uic-and-fundacio-ace/2019-02-14T10:35:43+01:00https://udic.es/la-udic-lidera-el-reclutamiento-a-nivel-internacional-en-un-ensayo-de-fase-ii-en-enfermedad-de-alzheimer/2019-03-05T10:05:33+01:00https://udic.es/la-udic-lidera-el-reclutament-a-nivell-internacional-en-un-assaig-de-fase-ii-en-malaltia-dalzheimer/2019-03-01T12:04:02+01:00https://udic.es/the-udic-leads-international-recruitment-in-a-phase-ii-trial-in-alzheimers-disease/2019-03-01T12:05:31+01:00https://udic.es/continua-la-terapia-antiamiloide-en-alzheimer-inicial/2019-03-14T11:03:46+01:00https://udic.es/continua-la-terapia-antiamiloide-en-alzheimer-inicial/2019-03-14T11:06:10+01:00https://udic.es/anti-amyloid-therapy-in-initial-alzheimers-continues/2019-03-14T11:05:02+01:00https://udic.es/bomba-de-levodopa-en-parkinson-avanzado/2019-03-20T09:11:37+01:00https://udic.es/bomba-de-levodopa-en-parkinson-avancat/2019-03-20T09:04:02+01:00https://udic.es/advanced-parkinsons-disease-treated-with-a-levodopa-pump/2019-03-20T09:04:48+01:00https://udic.es/nueva-terapia-antidiscinetica-en-parkinson/2024-02-14T16:09:26+01:00https://udic.es/nova-terapia-antidiscinetica-en-parkinson/2019-03-20T13:13:09+01:00https://udic.es/new-antidiskinetic-therapy-in-parkinsons-disease/2019-03-20T13:20:39+01:00https://udic.es/aportacion-novedosa-al-tratamiento-de-las-fluctuaciones-motoras-en-parkinson/2024-02-14T16:08:08+01:00https://udic.es/novel-contribution-to-the-treatment-of-motor-fluctuations-in-parkinsons/2019-03-27T17:52:23+01:00https://udic.es/aportacio-innovadora-al-tractament-de-les-fluctuacions-motores-en-parkinson/2019-03-27T17:56:51+01:00https://udic.es/otra-diana-terapeutica-en-alzheimer/2024-02-14T16:06:47+01:00https://udic.es/another-terapeutic-target-in-alzheimer-disease/2024-02-14T16:07:10+01:00https://udic.es/una-altra-diana-terapeutica-en-alzheimer/2024-02-14T19:45:25+01:00https://udic.es/paralisis-supranuclear-progresiva-psp-una-terapia-innovadora/2024-02-14T16:05:25+01:00https://udic.es/progressive-supranuclear-paralysis-psp-an-innovative-therapy/2024-02-14T19:49:38+01:00https://udic.es/paralisi-supranuclear-progressiva-psp-una-terapia-innovadora/2024-02-14T19:44:15+01:00https://udic.es/infeccion-dental-y-alzheimer/2024-02-14T16:04:10+01:00https://udic.es/dental-infection-and-alzheimers/2019-09-16T09:11:56+02:00https://udic.es/infeccio-dental-i-alzheimer/2019-09-06T08:47:18+02:00https://udic.es/iniciamos-una-terapia-antiamiloidea-intravenosa-en-alzheimer-leve/2024-02-14T16:02:49+01:00https://udic.es/iniciem-una-terapia-antiamiloidea-intravenosa-en-alzheimer-lleu/2019-09-20T13:52:06+02:00https://udic.es/we-started-an-intravenous-antiamyloid-therapy-in-mild-alzheimers/2019-09-20T13:54:32+02:00https://udic.es/nuevos-ensayos-buscan-una-cura-para-evitar-100-millones-de-enfermos-en-2050/2024-02-07T14:13:58+01:00https://udic.es/nous-assaigs-busquen-una-cura-per-evitar-100-milions-de-malalts-en-2050/2024-02-07T14:16:14+01:00https://udic.es/new-clinical-trials-are-looking-for-a-cure-to-avoid-100-million-of-new-patients-in-2050/2024-02-07T14:17:37+01:00https://udic.es/un-nou-algoritme-permet-identificar-les-persones-amb-mes-risc-dalzheimer/2024-02-14T16:01:17+01:00https://udic.es/el-hospital-universitari-general-de-catalunya-referente-en-la-investigacion-del-alzheimer/2024-02-14T15:58:20+01:00https://udic.es/un-nuevo-algoritmo-permite-identificar-a-las-personas-con-mas-riesgo-de-alzheimer/2024-02-14T16:00:49+01:00https://udic.es/a-new-algorithm-allows-to-identify-the-people-with-more-alzheimers-risk/2019-11-05T11:08:00+01:00https://udic.es/lhospital-general-universitari-de-catalunya-un-referent-en-la-investigacio-sobre-lalzheimer/2019-11-05T11:14:51+01:00https://udic.es/the-general-university-hospital-of-catalonia-a-reference-in-alzheimers-research/2019-11-05T11:16:51+01:00https://udic.es/el-doctor-ernest-balaguer-de-lhospital-universitari-general-de-catalunya-parla-de-lalzheimer/2019-11-06T13:48:48+01:00https://udic.es/un-germen-dental-podria-influir-en-laparicio-de-lalzheimer/2019-11-06T12:58:36+01:00https://udic.es/la-nostra-unitat-dinvestigacio-de-parkinson-i-alzheimer/2019-11-06T14:07:12+01:00https://udic.es/el-doctor-ernest-balaguer-del-hospital-universitario-general-de-catalunya-habla-del-alzheimer/2019-11-07T18:40:54+01:00https://udic.es/un-germen-dental-podria-influir-en-la-aparicion-del-alzheimer/2019-11-07T18:46:58+01:00https://udic.es/nuestra-unidad-de-investigacion-de-parkinson-y-alzheimer/2019-11-07T18:46:07+01:00https://udic.es/dr-balaguer-of-the-general-university-hospital-of-catalonia-talks-about-alzheimers-disease/2019-11-07T18:48:46+01:00https://udic.es/dental-germ-in-patients-with-moderate-alzheimers-disease/2019-11-07T18:50:52+01:00https://udic.es/our-parkinsons-and-alzheimers-research-unit/2019-11-07T18:52:29+01:00https://udic.es/biogen-sol%c2%b7licitara-laprovacio-dun-nou-farmac-en-alzheimer-inicial/2024-02-14T15:57:01+01:00https://udic.es/biogen-solicitara-la-aprobacion-a-la-fda-de-un-nuevo-farmaco-en-alzheimer-inicial/2024-02-14T15:56:32+01:00https://udic.es/biogen-will-request-the-approval-to-fda-of-a-new-drug-in-early-alzheimers-disease/2019-11-13T11:05:33+01:00https://udic.es/bomba-de-levodopa-subcutanea-en-parkinson-avanzado/2024-02-14T15:50:47+01:00https://udic.es/bomba-de-levodopa-subcutanea-en-parkinson-avancat/2019-11-29T09:39:31+01:00https://udic.es/subcutaneous-levodopa-infusion-pump-in-advanced-parkinson/2019-11-29T09:37:30+01:00https://udic.es/una-terapia-innovadora-y-sorprendente-en-parkinson/2024-02-14T15:53:28+01:00https://udic.es/una-terapia-innovadora-y-sorprendente-en-parkinson/2024-02-14T15:53:04+01:00https://udic.es/an-innovative-and-surprising-therapy-in-parkinsons-disease/2019-11-29T10:55:45+01:00https://udic.es/tavapadon-cerevel-a-very-different-dopamine-agonist/2024-02-14T15:49:11+01:00https://udic.es/tavapadon-cerevel-un-agonista-de-la-dopamina-muy-diferente/2024-02-14T15:48:25+01:00https://udic.es/tavapadon-cerevel-un-agonista-de-la-dopamina-molt-diferent/2024-02-14T15:48:50+01:00https://udic.es/resultado-positivo-de-el-ensayo-de-grifols-en-alzheimer-ambar/2024-02-14T15:47:20+01:00https://udic.es/resultat-positiu-de-lassaig-de-grifols-en-alzheimer-ambar/2019-12-12T18:00:11+01:00https://udic.es/positive-result-of-the-grifols-trial-in-alzheimers-ambar/2019-12-12T18:02:16+01:00https://udic.es/nuestra-unidad-sigue-en-posicion-destacada/2024-02-14T15:44:36+01:00https://udic.es/la-nostra-unitat-segueix-en-posicio-destacada/2020-01-09T16:35:24+01:00https://udic.es/our-clinical-trials-unit-remains-in-prominent-position/2020-01-09T16:36:32+01:00https://udic.es/un-ensayo-sorprendente-de-fase-i-en-parkinson/2024-02-14T15:46:09+01:00https://udic.es/un-assaig-sorprenent-de-fase-i-en-parkinson/2020-01-09T16:39:35+01:00https://udic.es/an-amazing-phase-i-trial-in-parkinson/2020-01-09T16:40:36+01:00https://udic.es/el-general-de-cataluna-primer-hospital-de-espana-activado-para-el-ensayo-fase-i-en-parkinson-reason/2020-01-17T13:35:05+01:00https://udic.es/10967/2021-11-18T09:55:26+01:00https://udic.es/the-general-hospital-of-catalonia-the-first-hospital-in-spain-to-be-activated-for-the-phase-i-trial-at-parkinsons-reason/2020-01-17T13:29:34+01:00https://udic.es/continuamos-un-ensayo-de-fase-i-en-parkinson-inicial/2024-02-14T15:40:59+01:00https://udic.es/we-continue-a-phase-i-clinical-trial-in-parkinson/2024-02-14T19:41:43+01:00https://udic.es/continuem-assaig-de-fase-i-en-parkinson/2020-03-05T13:22:53+01:00https://udic.es/activacion-ensayo-de-fase-i-en-paralisis-supranuclear-progresiva/2024-02-16T11:29:13+01:00https://udic.es/activacio-assaig-de-fase-i-en-paralisi-supranuclear-progressiva/2024-02-16T11:28:50+01:00https://udic.es/activation-of-phase-i-trial-in-progressive-supranuclear-paralysis/2024-02-16T11:28:23+01:00https://udic.es/bomba-dinfusio-de-levodopa/2024-02-16T11:26:56+01:00https://udic.es/bomba-de-infusion-de-levodopa-2/2020-04-02T18:46:40+02:00https://udic.es/levodopa-infusion-pump-2/2024-02-16T11:26:24+01:00https://udic.es/autorizada-en-eeuu-una-levodopa-intranasal/2024-02-16T11:24:30+01:00https://udic.es/autorizada-en-eeuu-una-levodopa-intranasal/2020-04-08T19:45:28+02:00https://udic.es/autoritzada-en-eua-una-levodopa-intranasal/2020-04-08T19:47:15+02:00https://udic.es/fda-aprueba-apomorfina-sublingual-en-bloqueos-off/2024-02-14T15:37:40+01:00https://udic.es/fda-approves-sublingual-apomorphine-in-off-periods/2020-07-23T10:59:15+02:00https://udic.es/la-fda-autoriza-apomorfina-sublingual-en-bloqueos-off/2024-02-14T15:37:09+01:00https://udic.es/la-udic-ha-inclos-el-primer-pacient-del-mon-en-un-assaig-clinic-de-fase-i-sobre-lalzheimer/2024-02-14T19:39:19+01:00https://udic.es/proven-un-farmac-per-tractar-lagitacio-en-malalts-dalzheimer/2024-02-14T15:34:02+01:00https://udic.es/la-udic-ha-incluido-el-primer-paciente-del-mundo-en-un-ensayo-clinico-de-fase-i-en-alzheimer/2024-02-14T15:35:06+01:00https://udic.es/la-udic-ha-inclos-el-primer-pacient-del-mon-en-un-assaig-clinic-de-fase-i-sobre-lalzheimer/2024-02-14T15:36:16+01:00https://udic.es/probamos-un-farmaco-para-tratar-la-agitacion-en-enfermos-de-alzheimer/2024-02-14T15:33:10+01:00https://udic.es/we-tested-a-drug-to-treat-agitation-in-alzheimers-patients/2021-06-03T10:45:22+02:00https://udic.es/el-hugc-incluye-pacientes-en-el-ensayo-de-fase-i-reason-en-parkinson/2021-06-08T10:16:03+02:00https://udic.es/el-hugc-incluye-al-primer-paciente-del-mundo-en-un-nuevo-ensayo-clinico-de-alzheimer/2021-06-08T10:24:09+02:00https://udic.es/el-hugc-inclou-pacients-en-lassaig-de-fase-i-reason-en-parkinson/2021-11-18T09:54:16+01:00https://udic.es/hugc-includes-patients-in-phase-i-reason-trial-in-parkinsons/2021-06-08T12:15:14+02:00https://udic.es/el-hugc-inclou-a-el-primer-pacient-de-el-mon-en-un-nou-assaig-clinic-dalzheimer/2021-11-09T10:39:57+01:00https://udic.es/hugc-includes-worlds-first-patient-in-new-alzheimers-clinical-trial/2021-06-08T12:19:08+02:00https://udic.es/estos-son-los-diez-mejores-neurologos-de-los-hospitales-catalanes/2022-03-25T13:14:21+01:00https://udic.es/aquests-son-els-deu-millors-neurolegs-dels-hospitals-catalans/2021-12-03T09:29:55+01:00https://udic.es/clarity-ad-que-ha-demostrado-reducir-la-tasa-de-deterioro-cognitivo-un-27-en-enfermos-de-alzheimer/2024-02-14T15:30:20+01:00https://udic.es/la-vacuna-pasiva-contra-el-alzheimer-tiene-una-eficacia-sorprendentemente-alta-segun-el-doctor-ernest-balaguer/2023-03-23T10:57:12+01:00https://udic.es/nuevo-farmaco-para-la-enfermedad-de-alzheimer/2024-02-16T10:15:43+01:00https://udic.es/farmac-nou-per-a-la-malaltia-dalzheimer/2024-02-16T10:14:36+01:00https://udic.es/new-drug-for-early-stage-alzheimers-disease/2024-02-16T10:14:01+01:00https://udic.es/la-vacuna-passiva-contra-lalzheimer-te-una-eficacia-sorprenentment-alta-segons-el-doctor-ernest-balaguer/2023-04-03T17:38:07+02:00https://udic.es/lassaig-clinic-clarity-ad-ha-demostrat-reduir-la-taxa-de-deterioracio-cognitiva-un-27-en-malalts-dalzheimer/2023-04-03T17:49:56+02:00https://udic.es/autorizada-en-nuestro-pais-la-nueva-levodopa-inhalada-inbrija/2024-02-14T15:23:45+01:00https://udic.es/new-inhaled-levodopa-inbrija-authorised-in-spain/2024-02-14T19:54:21+01:00https://udic.es/autoritzada-al-nostre-pais-la-nova-levodopa-inhalada-inbrija/2024-02-14T19:37:05+01:00https://udic.es/resultado-positivo-del-ensayo-pivotal-con-levodopa-administrada-mediante-infusion-subcutanea-continua/2024-02-14T15:22:37+01:00https://udic.es/resultat-positiu-de-lassaig-pivotal-amb-levodopa-administrada-mitjancant-infusio-subcutania-continua/2024-02-14T19:35:56+01:00https://udic.es/positive-result-from-the-pivotal-trial-with-levodopa-administered-by-continuous-subcutaneous-infusion/2024-02-14T19:50:35+01:00https://udic.es/una-opcion-para-pacientes-con-parkinson-y-mutacion-lrrk2/2024-02-14T15:21:47+01:00https://udic.es/an-option-for-patients-with-parkinsons-and-lrrk2-mutation/2023-11-21T15:22:02+01:00https://udic.es/una-opcion-de-modificar-el-curso-progresivo-del-parkinson/2024-02-14T19:34:36+01:00https://udic.es/an-option-to-modify-the-progressive-course-of-parkinsons/2023-11-21T15:35:23+01:00https://udic.es/una-opcion-para-pacientes-con-parkinson-y-mutacion-lrrk2/2024-02-14T15:21:12+01:00https://udic.es/an-option-for-patients-with-parkinsons-and-lrrk2-mutation-2/2024-02-14T19:48:01+01:00https://udic.es/an-option-to-modify-the-course-of-parkinsons-progression/2024-02-14T19:47:04+01:00https://udic.es/una-opcion-para-modificar-el-curso-de-la-progresion-del-parkinson/2024-02-14T15:16:29+01:00https://udic.es/avances-clinicos-en-el-tratamiento-de-parkinson-y-alzheimer-una-mirada-a-las-contribuciones-de-la-udic/2024-02-16T11:35:52+01:00https://udic.es/la-importancia-de-los-ensayos-clinicos-en-la-medicina-moderna/2024-02-15T12:50:46+01:00https://udic.es/colaboraciones-multidisciplinarias-en-investigacion-medica-un-enfoque-integral-para-avances-medicos/2024-02-15T13:02:14+01:00https://udic.es/retain-cuando-se-trata-de-la-enfermedad-de-alzheimer-ser-proactivo-puede-ser-util/2025-07-02T13:25:46+02:00